CDLX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cardlytics Inc (CDLX) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is currently in a bearish trend with poor financial performance, declining analyst ratings, and no positive catalysts. The lack of recent AI Stock Picker or SwingMax signals further weakens the case for investment.
The stock is in a bearish trend with negatively expanding MACD, RSI at 44.312 (neutral zone), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The price is below key pivot levels, with support at 0.911 and resistance at 1.049.
Hedge funds are increasing their buying activity, with a 361.26% increase in the last quarter.
Insiders are selling, with a 171.74% increase in selling activity over the last month. Financial performance is deteriorating, with significant YoY declines in revenue (-24.19%), net income (-47.08%), and EPS (-51.61%). Analysts have lowered price targets and maintain neutral ratings. No recent news or congress trading data to support a positive outlook.
In Q4 2025, revenue dropped to $56.1M (-24.19% YoY), net income dropped to -$8.25M (-47.08% YoY), EPS dropped to -0.15 (-51.61% YoY), and gross margin dropped to 45.45% (-3.28% YoY).
Analysts have lowered price targets, with Evercore ISI reducing the target to $1 and Lake Street reducing it to $1.25. Both firms maintain neutral ratings, citing the impact of the BofA exit and Bridg divestiture.
